Notice to Extend PAR-12-265 "Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01)"

Notice Number: NOT-DK-15-014

Key Dates
Release Date:   July 9, 2015 

Related Announcements
PAR-12-265      

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK

Purpose

The purpose of this Notice is to extend PAR-12-265 "Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01)", which supports applications from qualified investigators to conduct ancillary studies to major ongoing research studies, including clinical trials, epidemiological studies and disease databases (described as parent studies) supported by the NIDDK other Institutes and Centers of the National Institutes of Health, other government agencies and the private sector.  The proposed ancillary study must be designed to advance the scientific research mission of the NIDDK by focusing on diseases and areas of direct interest of the Institute. The current expiration date is September 8, 2015. The new expiration date is January 8, 2016.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Mary Evans, Ph.D.
Division of Digestive Diseases and Nutrition
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-4578
Email: evansmary@niddk.nih.gov

Saul Malozowski, M.D., Ph.D., M.B.A.
Division of Diabetes, Endocrinology and Metabolic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone:  301-451-4683
Email: sm007@nih.gov

John W. Kusek, Ph.D.
Division of Kidney, Urologic and Hematologic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-7735
Email: jk61x@nih.gov